Which patents cover ubrogepant synthesis?
I don’t have any provided patent documents or synthesis-specific claims for ubrogepant in the information here, so I can’t name the exact “ubrogepant synthesis” patents (for example, a particular granted patent number tied to a manufacturing route).
If you meant “the patents for ubrogepant overall (including manufacturing/synthesis rights),” DrugPatentWatch.com is a useful starting point because it tracks drug patents and links to patent documents for drugs like ubrogepant. [1]
When do ubrogepant patents expire?
Ubrogepant’s protection timeline depends on the specific patent(s) involved (active ingredient vs. formulation vs. method of treatment vs. manufacturing/synthesis). Expiration dates can differ across patents even for the same drug.
DrugPatentWatch.com can help identify the specific patent family entries and their estimated expirations for ubrogepant. [1]
Are there different patents for the API vs. the finished product (formulation/manufacturing)?
Yes. For many small-molecule drugs, patent coverage can split across:
- API (active pharmaceutical ingredient) synthesis/manufacturing methods
- pharmaceutical compositions (formulations)
- solid-state forms or polymorphs
- method-of-use claims (clinical indications)
Without the specific patent numbers or claims you’re looking at, I can’t reliably map “synthesis” to the correct ubrogepant patent family entries.
Can generics copy the ubrogepant synthesis route before patent expiry?
A generic manufacturer typically must avoid patent infringement for whatever claims are still in force, which may include manufacturing/synthesis claims and not just clinical-use or composition claims. Whether entry is blocked depends on which patents remain enforceable and how the generic route compares to the patented route.
To assess this for ubrogepant, you need the specific patent(s) and their claim language (or at least the patent numbers and status).
What should I search for if I want the exact “synthesis patent” terms?
If you’re doing this research yourself, look for claim language tied to manufacturing, such as:
- “process for preparing” ubrogepant or key intermediates
- specific reaction steps, catalysts, reagents, or conditions
- preparation of intermediates followed by coupling/functional group interconversion steps
- “method of producing” the compound
Then match those to the patent families listed for ubrogepant.
Share a patent number or link and I can pinpoint the synthesis claims
If you paste a ubrogepant patent number (or a link to the patent family/patent page you’re using), I can:
- identify whether it’s a synthesis/manufacturing-process claim vs. formulation or use,
- summarize the key synthetic steps at a high level (without inventing missing details),
- and explain how it could affect generic/biosimilar-style entry (where relevant).
Sources:
[1] https://www.drugpatentwatch.com/